Former Sen. Ben Sasse of Nebraska reveals an experimental cancer drug helped shrink his tumors by 76% after a stage 4 ...

The 17th annual PanCAN PurpleStride event in West Boca Raton united hundreds of participants to raise funds and awareness for ...

The former Nebraska senator shared how his terminal cancer diagnosis has shaped his view of family, faith and the current ...

Follow along as the PanCAN community speaks up, stands together and contacts Congress to prioritize patients and researchers ...

Erasca is developing a competitor to Revolution Medicines’ daraxonrasib.

Fresh off a major clinical win, Revolution Medicines alleges that Erasca’s pancreatic cancer drug infringes on key patent ...

PanCAN has always led the way and our bold campaign is no different. It comes at an extraordinary time in pancreatic cancer ...

Our fraught national debate over immunization and public health has overshadowed some extremely encouraging advances being ...

There is some promising news for pancreatic cancer research, as medical data show lasting results from the trial of a vaccine ...

New clinical trial data show KRAS-blocking drugs may significantly improve survival for the disease. “I think this is truly ...

PurpleStride Pittsburgh was a big success this weekend, raising $475,000 and counting to fight pancreatic cancer.

The novel personalized mRNA vaccine also demonstrates the potential for such vaccines in other solid tumor types.